Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors

Katsue Miyoshi, Yasumasa Ohyagi, Nobutaka Sakae, Kyoko Motomura, Linqing Ma, Takayuki Taniwaki, Hirokazu Furuya, Takeshi Tabira, Jun-Ichi Kira

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Presenilin 1 (PS1) gene mutations are the major causes of early-onset familial Alzheimer's disease. Acceleration of apoptosis is one of the major pathogenic mechanisms of PS1 mutants, and PS1 mutants have also been reported to induce overproduction of amyloid-β protein 42. Here, we investigated aberrancy in activation of initiator caspases related to two PS1 gene mutations, I143T and G384A. Acceleration of apoptosis, elevation of caspase-3/7 activity, and significant increases in caspase-4, -8 and -9 activities during apoptosis induced by several agents were found in these mutant PS1-transfected cells. Interestingly, thapsigargin treatment enhanced caspase-4 and -9 activities in I143T-mutant PS1-transfected cells, while hydrogen peroxide treatment enhanced caspase-4, -8 and -9 activities in G384A-mutant PS1-transfected cells, indicating diverse apoptosis-promoting effects of PS1 gene mutations. In addition, treatment with a β-secretase inhibitor or γ-secretase inhibitor significantly attenuated the effects of the PS1 mutants on caspase-3/7 activation and recovered cell viability. Our present data suggest that these PS1 mutants accelerate the activation of initiator caspases and promote apoptosis, which may be associated, at least in part, with amyloid-β production.

Original languageEnglish
Pages (from-to)551-564
Number of pages14
JournalJournal of Alzheimer's Disease
Volume16
Issue number3
DOIs
Publication statusPublished - Jan 1 2009

Fingerprint

Presenilin-1
Caspase 1
Amyloid Precursor Protein Secretases
Mutation
Genes
Apoptosis
Initiator Caspases
Caspase 7
Caspase 8
Caspase 3
Alzheimer Disease
Inhibition (Psychology)
Amyloidogenic Proteins
Thapsigargin
Caspase 9
Amyloid
Hydrogen Peroxide
Cell Survival

All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors. / Miyoshi, Katsue; Ohyagi, Yasumasa; Sakae, Nobutaka; Motomura, Kyoko; Ma, Linqing; Taniwaki, Takayuki; Furuya, Hirokazu; Tabira, Takeshi; Kira, Jun-Ichi.

In: Journal of Alzheimer's Disease, Vol. 16, No. 3, 01.01.2009, p. 551-564.

Research output: Contribution to journalArticle

Miyoshi, K, Ohyagi, Y, Sakae, N, Motomura, K, Ma, L, Taniwaki, T, Furuya, H, Tabira, T & Kira, J-I 2009, 'Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors', Journal of Alzheimer's Disease, vol. 16, no. 3, pp. 551-564. https://doi.org/10.3233/JAD-2009-0989
Miyoshi, Katsue ; Ohyagi, Yasumasa ; Sakae, Nobutaka ; Motomura, Kyoko ; Ma, Linqing ; Taniwaki, Takayuki ; Furuya, Hirokazu ; Tabira, Takeshi ; Kira, Jun-Ichi. / Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors. In: Journal of Alzheimer's Disease. 2009 ; Vol. 16, No. 3. pp. 551-564.
@article{38455b956e8e4ba6beb64cf9833c5a94,
title = "Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors",
abstract = "Presenilin 1 (PS1) gene mutations are the major causes of early-onset familial Alzheimer's disease. Acceleration of apoptosis is one of the major pathogenic mechanisms of PS1 mutants, and PS1 mutants have also been reported to induce overproduction of amyloid-β protein 42. Here, we investigated aberrancy in activation of initiator caspases related to two PS1 gene mutations, I143T and G384A. Acceleration of apoptosis, elevation of caspase-3/7 activity, and significant increases in caspase-4, -8 and -9 activities during apoptosis induced by several agents were found in these mutant PS1-transfected cells. Interestingly, thapsigargin treatment enhanced caspase-4 and -9 activities in I143T-mutant PS1-transfected cells, while hydrogen peroxide treatment enhanced caspase-4, -8 and -9 activities in G384A-mutant PS1-transfected cells, indicating diverse apoptosis-promoting effects of PS1 gene mutations. In addition, treatment with a β-secretase inhibitor or γ-secretase inhibitor significantly attenuated the effects of the PS1 mutants on caspase-3/7 activation and recovered cell viability. Our present data suggest that these PS1 mutants accelerate the activation of initiator caspases and promote apoptosis, which may be associated, at least in part, with amyloid-β production.",
author = "Katsue Miyoshi and Yasumasa Ohyagi and Nobutaka Sakae and Kyoko Motomura and Linqing Ma and Takayuki Taniwaki and Hirokazu Furuya and Takeshi Tabira and Jun-Ichi Kira",
year = "2009",
month = "1",
day = "1",
doi = "10.3233/JAD-2009-0989",
language = "English",
volume = "16",
pages = "551--564",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors

AU - Miyoshi, Katsue

AU - Ohyagi, Yasumasa

AU - Sakae, Nobutaka

AU - Motomura, Kyoko

AU - Ma, Linqing

AU - Taniwaki, Takayuki

AU - Furuya, Hirokazu

AU - Tabira, Takeshi

AU - Kira, Jun-Ichi

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Presenilin 1 (PS1) gene mutations are the major causes of early-onset familial Alzheimer's disease. Acceleration of apoptosis is one of the major pathogenic mechanisms of PS1 mutants, and PS1 mutants have also been reported to induce overproduction of amyloid-β protein 42. Here, we investigated aberrancy in activation of initiator caspases related to two PS1 gene mutations, I143T and G384A. Acceleration of apoptosis, elevation of caspase-3/7 activity, and significant increases in caspase-4, -8 and -9 activities during apoptosis induced by several agents were found in these mutant PS1-transfected cells. Interestingly, thapsigargin treatment enhanced caspase-4 and -9 activities in I143T-mutant PS1-transfected cells, while hydrogen peroxide treatment enhanced caspase-4, -8 and -9 activities in G384A-mutant PS1-transfected cells, indicating diverse apoptosis-promoting effects of PS1 gene mutations. In addition, treatment with a β-secretase inhibitor or γ-secretase inhibitor significantly attenuated the effects of the PS1 mutants on caspase-3/7 activation and recovered cell viability. Our present data suggest that these PS1 mutants accelerate the activation of initiator caspases and promote apoptosis, which may be associated, at least in part, with amyloid-β production.

AB - Presenilin 1 (PS1) gene mutations are the major causes of early-onset familial Alzheimer's disease. Acceleration of apoptosis is one of the major pathogenic mechanisms of PS1 mutants, and PS1 mutants have also been reported to induce overproduction of amyloid-β protein 42. Here, we investigated aberrancy in activation of initiator caspases related to two PS1 gene mutations, I143T and G384A. Acceleration of apoptosis, elevation of caspase-3/7 activity, and significant increases in caspase-4, -8 and -9 activities during apoptosis induced by several agents were found in these mutant PS1-transfected cells. Interestingly, thapsigargin treatment enhanced caspase-4 and -9 activities in I143T-mutant PS1-transfected cells, while hydrogen peroxide treatment enhanced caspase-4, -8 and -9 activities in G384A-mutant PS1-transfected cells, indicating diverse apoptosis-promoting effects of PS1 gene mutations. In addition, treatment with a β-secretase inhibitor or γ-secretase inhibitor significantly attenuated the effects of the PS1 mutants on caspase-3/7 activation and recovered cell viability. Our present data suggest that these PS1 mutants accelerate the activation of initiator caspases and promote apoptosis, which may be associated, at least in part, with amyloid-β production.

UR - http://www.scopus.com/inward/record.url?scp=65549124117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549124117&partnerID=8YFLogxK

U2 - 10.3233/JAD-2009-0989

DO - 10.3233/JAD-2009-0989

M3 - Article

C2 - 19276550

AN - SCOPUS:65549124117

VL - 16

SP - 551

EP - 564

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -